Products 59282-56-3

CAS 59282-56-3 appears in our catalog under these names: Lindleyin/ 99.74% (existing batch purity), Lindleyin, Lindleyin 99%, Lindleyin, 99%, 99%, Lindleyin, 99.95%. Offered by: TargetMol, GLPBio, Ambeed, Chemat, MedChemExpress. Available pack sizes: 1mg, 5mg, 10mg, 1 mg, 5 mg.

Lindleyin/ 99.74% (existing batch purity)
TargetMol
  • size: 1mg, 5mg, 10mg
  • Variants: 3
from 1030.12
View product
Lindleyin
GLPBio
  • size: 1mg, 5mg
  • Variants: 2
from 1238.27
View product
Lindleyin 99%
Ambeed
  • size: 1mg, 5mg, 10mg
  • Variants: 3
from 631.81
View product
Lindleyin, 99%, 99%
Chemat
  • size: 10mg
  • Variants: 1
from 1835.60
View product
Lindleyin, 99.95%
MedChemExpress
  • size: 1 mg, 5 mg
  • Variants: 2
from 886.26
View product
Structural formula: {0} (CAS {1})

Lindleyin is a glycoside.

Source: ChEBI

Identity
Molecular formulaC23H26O11
Molecular weight478.4 g/mol
IUPAC name[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-(3-oxobutyl)phenoxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
InChIKeyBJYRNIFAMMOVGW-OXUVVOBNSA-N
SMILESCC(=O)CCC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)C3=CC(=C(C(=C3)O)O)O)O)O)O

Computed by PubChem (NCBI)

Synonyms: Lindleyin, 4-(4'-Hydroxyphenyl)-2-butanone-4'-O-beta-D-(6''-O-gallyl)glucopyranoside, 4-(3-Oxobutyl)phenyl 6-O-(3,4,5-trihydroxybenzoyl)hexopyranoside, (4-(4'-Hydroxyphenyl)-2-butanone-4'-O-beta-D-(6''-O-gallyl)glucopyranoside), orb1220067, orb1297583, 4-(3-oxobutyl)phenyl 6-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranoside, 2-Butanone,4-[4-[[6-O-(3,4,5-trihydroxybenzoyl)-b-D-glucopyranosyl]oxy]phenyl]-, 4-(4'-hydroxyphenyl)-2-butanone-4'-O-beta-D-(6''-O-galloyl)-glucopyranoside
Isomers (same molecular formula)
2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-hydroxy-5,7-bis(2-hydroxyethoxy)chromen-4-one C23H26O11
2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-3,7-bis(2-hydroxyethoxy)chromen-4-one C23H26O11
(2S)-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one C23H26O11
[(2R,3S,4S,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate C23H26O11
[(2R,3S,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate C23H26O11
[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[4-(3-oxobutyl)phenoxy]oxan-3-yl] 3,4,5-trihydroxybenzoate C23H26O11
3-[(2R,3R,4aR,6R,7S,8S,8aR)-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-6-(hydroxymethyl)-3,4a,6,7,8,8a-hexahydro-2H-pyrano[2,3-b][1,4]dioxin-3-yl]-1-(3,4-dihydroxyphenyl)propan-1-one C23H26O11
(2R,3R,4S,5S,6R)-2-[(1R,2R)-1,5-bis(3,4-dihydroxyphenyl)-1-hydroxypent-4-yn-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol C23H26O11